Restraint control of lung inflammation by CD200Fc was also observed in an asthma model where CD200Fc reduced airway hyperresponsiveness and IL-13 level without modulating cell recruitment and eosinophil levels in BALs (22). The gene discussed is IL13; the disease is airway hyperresponsiveness.